ClinConnect ClinConnect Logo
Search / Trial NCT01805986

Investigation of GM Pathology Using Ultra High Field (7T) MRI Scanner

Launched by UNIVERSITY OF NOTTINGHAM · Mar 5, 2013

Trial Information

Current as of August 02, 2025

Unknown status

Keywords

Multiple Sclerosis, Other Neurological Conditions

ClinConnect Summary

Purpose for this study:

This research group has previously investigated the usefulness of a powerful new MRI scanner and have found that the 7 Tesla MRI is able to provide detailed structural images of the cortex of the brain which can uncover pathology such as cortical demyelinating lesions in MS patients. Multiple sclerosis (MS) affects the grey matter as well as the white matter of the brain and spinal cord. However as white matter lesions are more easily visible both pathologically and on MRI, therefore most MS research has focused on white matter demyelination. The investigators would...

Gender

ALL

Eligibility criteria

  • Inclusion criteria:
  • Patients with MS or other neurological disease which already had at least 1 MRI scan.
  • Healthy volunteers which had no indication of neurological disease in the past.
  • Do not have significant cognitive impairment and are able to give consent.
  • Will not have any contraindication for MR imaging
  • Are able to lie flat for up to 60 mins.
  • Age 25 and over.
  • Exclusion criteria:
  • Pregnancy
  • Have any implants in the body.
  • Have aneurysm clips.
  • Have pacemaker or artificial heart valve.
  • Have foreign bodies in their body (e.g. shrapnel).

About University Of Nottingham

The University of Nottingham is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge research and expert faculty to address pressing medical challenges. Through its dedicated clinical trials unit, the University of Nottingham conducts rigorous studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. The institution prioritizes ethical practices and participant safety, ensuring that all trials are designed to uphold the highest standards of scientific integrity and regulatory compliance.

Locations

Patients applied

0 patients applied

Trial Officials

Nikos Evangelou, PhD

Principal Investigator

University of Nottingham

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials